4.7 Letter

Luspatercept for myelodysplastic syndromes/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis

Journal

LEUKEMIA
Volume 36, Issue 5, Pages 1432-1435

Publisher

SPRINGERNATURE
DOI: 10.1038/s41375-022-01521-4

Keywords

-

Funding

  1. Celgene
  2. Bristol-Myers Squibb Company
  3. Acceleron Pharma
  4. Bristol Myers Squibb

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available